Searched for
IVF TRUSTEE COMPANY
Indira IVF, Chartered Speed, Jerai Fitness among 8 IPOs approved by SebiSebi has cleared eight companies, including Indira IVF, Chartered Speed, Glass Wall Systems, Shriram Food Industry, RKCPL, Tempsens Instrum...- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 38%While it might be too early to call or to some it might appear to be wish of which bears on the street would have, but the way the market b...
- When valuations are not cheap: 5 largecap stocks from different sectors with upside potential of up to 27%It is after a long period that some of the macro factors have turned favorable for Indian markets. The recent decline in oil prices despite...
- Foreign Investment Promotion Board to take up 25 foreign direct investment proposals on September 22FIPB will take up 25 FDI proposals, including those of Aditya Birla Nuvo, Cipla, Sun Pharma Advanced Research and HDFC Capital Advisors
- Syngene International makes stellar debut, ends day up 24% over issue priceIt hit an intraday high of Rs 318.20 over its issue price, before settling the day at Rs 310.40, up 24.16 per cent on the BSE.
- First pharma IPO in 5 years: Syngene’s debut offer subscribed 32 timesThe Rs 550-crore initial public offer of Syngene, a research arm of Biocon, was subscribed 32 times on the final day of the offer
- Syngene IPO gets robust response; issue subscribed 32 timesThe Rs 550 crore IPO of Syngene International was over-subscribed 32.03 times on the last day of the offer today as both retail and institu...
- Syngene IPO over-subscribed on second dayThe IPO got bids for 1,60,79,700 shares against 1,60,00,000 shares on offer, resulting in a subscription of 1.01 (rpt) 1.01 times, accordin...
- Syngene IPO subscribed 32% on Day 1The initial public offering of biotechnology major Biocon's research arm Syngene International was subscribed 32 per cent on the first day ...
- Syngene gets FIPB nod to raise foreign investment to 44%Syngene, a subsidiary of Biocon, said it has received the Foreign Investment Promotion Board approval to raise foreign investment to 44 per...
- Biocon's arm Syngene International gets Sebi approval for IPOThe company plans to sell 22 mn equity shares, including reservation of up to two mn shares for Biocon shareholders.
- Biocon surges as company files prospectus for Syngene IPO to raise Rs 600 crore; ends in redBiocon surged over 3% in intraday trade on Thursday after the company filed prospectus for Syngene IPO on Wednesday to raise Rs 600 cr .
- Biocon arm Syngene appoints Peter Bains as CEOBains has been a director of Syngene, since 2011. Syngene had yesterday said it would set up a new plant at Mangalore SEZ to manufacture ph...
- Sensex, Nifty trade in a narrow range; top twelve stocks in focusSensex pared most of its morning gains and was trading in a narrow range, weighed down by losses in Infy, ONGC, RIL, Tata Motors and L&T.
- Twelve stocks in focus in Tuesday morning tradeIndian markets are expected to trade in a range. Here is a list of twelve stocks which are likely to be in focus today.
- Biocon completes 10 per cent stake sale in SyngeneBiotechnology major Biocon today concluded sale of 10 per cent stake in its research arm Syngene for Rs 380 crore to IVF Trustee Company Pr...
- Financial Technologies seeks shareholders nod for sale of NBHCFinancial Technologies (FTIL) today sought shareholders' approval for sale of its subsidiary National Bulk Handling Corporation (NBHC).
- Trustee of Kiran Bedi's NGO quits, claims his reputation tarnishedTeam Anna member Kiran Bedi today faced problems from within when one of the founder members of her NGO managing her trips quit the trust.
- Trustee of Kiran Bedi's NGO quits, claims his reputation tarnishedTeam Anna member Kiran Bedi today faced problems from within when one of the founder members of her NGO managing her trips quit the trust.
Load More
